ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2024; 49(3): 661-664


In vitro insights: Investigating pro-apoptotic potential of capsaicin against HL-60, Human Leukemia cell line

Hafiz Muhammad Haseeb Khaliq, Owais Aziz, Monika Wadhwa, Shahla Imran.



Abstract
Download PDF Post

Objective: To investigate the pro-apoptotic potential of capsaicin on Human Leukemia HL-60 cell line as a potent natural chemotherapeutic agent.
Methodology: This study was conducted at Forman Christian College, Lahore from January to April-2024. It included culturing HL-60 cell line and its treatment with serial concentrations of capsaicin for calculation of subsequent IC50 values via MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay, expression analysis of gene, comparative analysis of relative gene fold (Intrinsic Biomarkers Caspase-3, Caspase-9) as apoptosis mediator markers followed by RT-qPCR. Cellular apoptotic morphology was confirmed via Hoechst 333258 staining.
Results: For HL-60 cell line, the IC50 of capsaicin (16.7uM) showed high gene expression of pro-apoptotic biomarkers (Caspase-3 and Caspase-9). Hoechst 333258 staining showed prominent apoptotic bodies leading to nuclear fragmentations.
Conclusion: Capsaicin had robust pro-apoptotic potential leading to diagnostic efficacy against leukemia HL-60 cell line. Further studies would help in identifying key mechanisms by which capsaicin exhibits anti-apoptotic potential against HL-60 cell lines.

Key words: Capsaicin, pro-apoptotic effects, anti-cancer mechanisms, HL-60, natural chemotherapeutics.





Bibliomed Article Statistics

21
29
27
35
30
36
23
16
8
18
16
16
R
E
A
D
S

21

16

30

16

9

20

12

11

7

11

10

14
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.